Yi Cui

Specialty: Nanomedicine

Location: United States

Tier: TITAN

H-Index: 299

Years Active: 0

Hospital Affiliations

• Stanford University - Faculty

Key Publications

1. "A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features." - Nat Med (2024)
2. "Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164." - J Clin Oncol (2020)
3. "Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164." - Eur J Cancer (2023)
4. "Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer." - Cell (2024)
5. "Advances in Microgravity Directed Tissue Engineering." - Adv Healthc Mater (2023)

Knowledge Graph Relationships

Yi Cui is a Nanomedicine specialist affiliated with Stanford University. Authored 5 scholarly articles.